\begin{table}
\caption{
Details of 45 protein design test cases with continuous flexibility run on both \osprey 2.2 and \osprey 3.0.  Test cases primarily adapted from Ref.~\citen{EPIC}.  $^a$ Y indicates a partition function calculation (a subroutine of the $K^*$ algorithm~\cite{K*,minDEE}), which analyzes a thermodynamic ensemble of conformations; N indicates calculation of the single global minimum-energy conformation (GMEC). DNF: Did not finish.  }
\resizebox{\textwidth}{!}{
\begin{tabular}{|p{1.9in}|p{0.5in}|p{0.3in}|p{0.6in}|p{0.75in}|p{0.75in}|p{0.75in}|}
\hline
Protein name	&	PDB code	&	PF?$^a$ 	&	Mutable residue count	&	OSPREY 3.0 time (min)	&	OSPREY 2.2 time (min)	&	Speedup	\\ \hline
Scorpion toxin	&	1AHO	&	N	&	7	&	0.37	&	2.75	&	7.38	\\ \hline
Scorpion toxin	&	1AHO	&	N	&	9	&	0.64	&	6.60	&	10.35	\\ \hline
Scorpion toxin	&	1AHO	&	N	&	12	&	194.71	&	1608.16	&	8.26	\\ \hline
Scorpion toxin	&	1AHO	&	N	&	14	&	287.87	&	2075.04	&	7.21	\\ \hline
Cytochrome c553	&	1C75	&	N	&	6	&	0.28	&	4.30	&	15.19	\\ \hline
Atx1 metallochaperone	&	1CC8	&	N	&	7	&	2.56	&	85.41	&	33.41	\\ \hline
Atx1 metallochaperone	&	1CC8	&	Y	&	7	&	67.12	&	DNF	&	$>$364.72$^\dagger$	\\ \hline
Bucandin	&	1F94	&	N	&	7	&	0.40	&	4.82	&	12.07	\\ \hline
Nonspecific lipid-transfer protein	&	1FK5	&	N	&	6	&	0.03	&	0.78	&	27.34	\\ \hline
Transcription factor IIF	&	1I27	&	N	&	7	&	1.58	&	385.56	&	244.4	\\ \hline
Ferredoxin 	&	1IQZ	&	N	&	9	&	0.16	&	2.45	&	14.92	\\ \hline
Trp repressor 	&	1JHG	&	N	&	7	&	2.88	&	22.50	&	7.8	\\ \hline
Fructose-6-phosphate aldolase 	&	1L6W	&	N	&	6	&	0.23	&	75.97	&	336.22	\\ \hline
Cephalosporin C deacetylase 	&	1L7A	&	N	&	8	&	4.09	&	928.27	&	226.93	\\ \hline
PA-I lectin 	&	1L7L	&	N	&	6	&	0.12	&	6.26	&	52.85	\\ \hline
Phosphoserine phosphatase 	&	1L7M 	&	N	&	7	&	1.13	&	249.33	&	220.11	\\ \hline
alpha-D-glucuronidase 	&	1L8N	&	N	&	5	&	0.13	&	480.13	&	3701.36	\\ \hline
Dachshund	&	1L8R	&	N	&	8	&	0.19	&	1.41	&	7.62	\\ \hline
\end{tabular}
}

$^\dagger$ \osprey 2.2 did not finish within the time limit, so we report a lower bound on the speedup: the ratio of the time limit (17 days) to the \osprey 3.0 runtime.   
(Table continues on next page)
\label{table:2v3}
\end{table}

\begin{table}
\resizebox{\textwidth}{!}{
\begin{tabular}{|p{1.9in}|p{0.5in}|p{0.3in}|p{0.6in}|p{0.75in}|p{0.75in}|p{0.75in}|}
\hline
Protein name	&	PDB code	&	PF?$^a$ 	&	Mutable residue count	&	OSPREY 3.0 time (min)	&	OSPREY 2.2 time (min)	&	Speedup	\\ \hline
Granulysin 	&	1L9L	&	N	&	7	&	0.06	&	1.24	&	20.8	\\ \hline
gamma-glutamyl hydrolase 	&	1L9X	&	N	&	5	&	0.03	&	92.13	&	3507.46	\\ \hline
Ferritin 	&	1LB3 	&	N	&	5	&	0.42	&	23.42	&	55.2	\\ \hline
Cytochrome c 	&	1M1Q 	&	N	&	8	&	1.68	&	357.59	&	213.09	\\ \hline
Hypothetical protein YciI 	&	1MWQ	&	N	&	8	&	0.13	&	3.69	&	28.13	\\ \hline
ygfY	&	1X6I	&	Y	&	14	&	604.71	&	DNF	&	$>$40.48$^\dagger$	\\ \hline
ADAR1 ZB domain	&	1XMK	&	Y	&	15	&	2172.23	&	DNF	&	$>$11.27$^\dagger$	\\ \hline
Histidine triad protein 	&	2CS7	&	Y	&	14	&	2816.56	&	DNF	&	$>$8.69$^\dagger$	\\ \hline
Transcriptional regulator AhrC 	&	2P5K	&	Y	&	11	&	1.18	&	DNF	&	$>$20811.61$^\dagger$	\\ \hline
Scytovirin 	&	2QSK	&	N	&	10	&	10.47	&	164.49	&	15.71	\\ \hline
Scytovirin 	&	2QSK	&	Y	&	10	&	2.54	&	9267.19	&	3651.9	\\ \hline
Hemolysin 	&	2R2Z	&	Y	&	12	&	42.02	&	DNF	&	$>$582.58$^\dagger$	\\ \hline
Putative monooxygenase 	&	2RIL	&	N	&	8	&	18.16	&	15.89	&	0.87	\\ \hline
Putative monooxygenase 	&	2RIL	&	Y	&	8	&	0.23	&	104.77	&	463.18	\\ \hline
alpha-crystallin 	&	2WJ5	&	Y	&	15	&	226.32	&	DNF	&	$>$108.17$^\dagger$	\\ \hline
Cytochrome c555 	&	2ZXY	&	Y	&	14	&	381.39	&	DNF	&	$>$64.19$^\dagger$	\\ \hline
High-potential iron-sulfur protein 	&	3A38	&	Y	&	13	&	65.15	&	DNF	&	$>$375.72$^\dagger$	\\ \hline
ClpS protease adaptor 	&	3DNJ	&	Y	&	12	&	65.04	&	DNF	&	$>$376.4$^\dagger$	\\ \hline
Putative monooxygenase 	&	3FGV	&	Y	&	10	&	1.94	&	DNF	&	$>$12591.94$^\dagger$	\\ \hline
Protein G 	&	3FIL	&	Y	&	14	&	303.81	&	DNF	&	$>$80.58$^\dagger$	\\ \hline
Viral capsid 	&	3G21	&	Y	&	15	&	188.53	&	DNF	&	$>$129.85$^\dagger$	\\ \hline
dpy-30-like protein 	&	3G36	&	N	&	4	&	1.55	&	9.97	&	6.43	\\ \hline
dpy-30-like protein 	&	3G36	&	Y	&	4	&	0.05	&	2.44	&	47.07	\\ \hline
Hfq protein 	&	3HFO	&	Y	&	10	&	6.81	&	DNF	&	$>$3594.09$^\dagger$	\\ \hline
Cold shock protein 	&	3I2Z	&	Y	&	14	&	20.84	&	DNF	&	$>$1174.8$^\dagger$	\\ \hline
HPI integrase	&	3JTZ	&	Y	&	14	&	859.69	&	DNF	&	$>$28.48$^\dagger$	\\ \hline
PSD-95 PDZ3 domain	&	1TP5	&	N	&	6	&	0.12	&	49.50	&	424.29	\\ \hline
\end{tabular}
}
\end{table}




\begin{table}[h]
\centering
\scriptsize
\resizebox{.49\linewidth}{!}{
\begin{tabular}{|K{1.3cm}|K{1.7cm}|K{2cm}|K{2cm}|}
\hline
 & Mutation(s) & Experimental Ranking & Computational Ranking\\
\hline
\parbox[t]{2mm}{\multirow{13}{*}{\rotatebox[origin=c]{90}{Barnase:Barstar, PDB ID: 1X1U}}} & D39A & 1 & 1\\
 & H102A & 2 & 3\\
 & R87A & 3 & 5\\
 & K27A & 4 & 8\\
 & R59A & 5 & 2\\
 & D35A & 6 & 4\\
 & Y29A & 7 & 7\\
 & E73A & 8 & 12\\
 & E76A & 9 & 6\\
 & W35F & 10 & 11\\
 & E60A & 11 & 10\\
 & Y29F & 12 & 9\\ \cline{3-4}
 && \multicolumn{2}{c|}{$\rho = 0.755$} \\
\hline
\parbox[t]{2mm}{\multirow{17}{*}{\rotatebox[origin=c]{90}{IL-2:IL-2R$\alpha$, PDB ID: 2B5I}}} & K38E, S39D & 1.5 & 1\\
 & R35T, R36S & 1.5 & 2\\
 & R35K, R36K & 3 & 4\\
 & E1K, D4K & 4 & 7\\
 & E29R & 5 & 5\\
 & L2A & 6 & 16\\
 & D4K & 7.5 & 9\\
 & S39A, S41A & 7.5 & 12\\
 & E1K & 9 & 11\\
 & H120A & 10 & 10\\
 & E29A & 11 & 6\\
 & L42S, Y43L & 12 & 3\\
 & E1Q & 13 & 14\\
 & N27A & 14 & 15\\
 & K38T & 15 & 8\\
 & D4N & 16 & 13\\ \cline{3-4} 
 && \multicolumn{2}{c|}{$\rho = 0.554$}  \\
\hline
\end{tabular}
}
\resizebox{.49\linewidth}{!}{
\begin{tabular}{|K{1.3cm}|K{1.7cm}|K{2cm}|K{2cm}|}
\hline
\multirow{6}{*}{\rotatebox[origin=c]{90}{\parbox[t]{2.5cm}{\centering Cyt{\it{c}}:Cyt{\it{c}} peroxidase, PDB ID: 2PCB}}} & E290N & 1 & 2\\
 & D34N & 2 & 4\\
 & A193F & 3 & 1\\
 & E35Q & 4 & 3\\ 
 & E32Q & 5 & 5\\ \cline{3-4}
 && \multicolumn{2}{c|}{$\rho = 0.500$} \\ 
\hline
\parbox[t]{2mm}{\multirow{20}{*}{\rotatebox[origin=c]{90}{IFN$\alpha$2:ifnar2, PDB ID: 3S9D}}} & \colorbox{LightCyan}{R33Q} & 1 & 1\\
 & R33A & 2 & 2\\
 & R33K & 3 & 5\\
 & L30A & 4 & 6\\
 & R149A & 5 & 4\\
 & L30V & 6 & 9\\
 & A148A & 7 & 10\\
 & A145G & 8 & 14\\
 & A145M & 9 & 3\\
 & L15A & 10 & 13\\
 & L153A & 11 & 12\\
 & L26A & 12 & 7\\
 & S152A & 13 & 16\\
 & F27A & 14 & 8\\
 & S25A & 15 & 18\\
 & D35A & 16 & 17\\
 & R22A & 17 & 11\\
 & M16A & 18 & 15\\
 & \colorbox{LightCyan}{N156A} & 19 & 19\\ \cline{3-4}
 && \multicolumn{2}{c|}{$\rho = 0.795$} \\
 \hline
 \multicolumn{2}{|c|}{} & {\textbf{Across All}} & $\rho = 0.762$ \\
\hline
\end{tabular}
}
\caption{\textbf{Comparison of \osprey predictions to experimental results for mutations in four protein systems.}  Allowed mutations for each system are listed along with their corresponding rankings from experimental measurements \cite{binding2barnase,bindingbarnase,bindingcytc,bindingifna2,bindingil2} vs. computational predictions by \ks from \osprey 3.0. The mutations highlighted in blue are shown in detail in Figure \ref{fig:designs}. A Spearman's $\rho$ value is calculated for each system and shown here. The ``Across All" value is calculated by ranking each system individually and then calculating the Spearman's $\rho$ across all of the designs.}
\label{table:spearman}
\end{table}



